Day Zero Diagnostics Names Jeff Mirviss Chair of Board of Directors
Day Zero Diagnostics announced today that independent board member, Jeff Mirviss, has been appointed board chair.
Article Date
October 24, 2023
This article is featured on another website.
Go to article
June 1, 2026
Chime Biologics and Daewoong Pharmaceutical Enter Strategic Partnership to Advance Dupilumab Biosimilar Development and Commercialization in Global Markets
June 1, 2026
Chime Biologics and Daewoong Pharmaceutical Enter Strategic Partnership to Advance Dupilumab Biosimilar Development and Commercialization in Global Markets
June 23, 2026
HiRO at BIO Asia–Taiwan: Advancing Global Clinical Development Together
Collaborating Across APAC at BIO Asia–Taiwan to Advance High‑Quality Cross‑Border Clinical Research Harvest Integrated Research…
June 23, 2026
HiRO at BIO Asia–Taiwan: Advancing Global Clinical Development Together
Collaborating Across APAC at BIO Asia–Taiwan to Advance High‑Quality Cross‑Border Clinical Research Harvest Integrated Research…